Akeso, Inc. (AKESF)
14.54
+0.74
(+5.38%)
USD |
OTCM |
Oct 09, 16:00
Akeso Price to Book Value : 215.01 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 215.01 |
| October 08, 2026 | 204.02 |
| October 07, 2026 | 204.02 |
| October 06, 2026 | 203.28 |
| October 05, 2026 | 203.28 |
| October 02, 2026 | 198.70 |
| October 01, 2026 | 200.55 |
| September 30, 2026 | 196.41 |
| September 29, 2026 | 192.19 |
| September 28, 2026 | 186.28 |
| September 25, 2026 | 186.28 |
| September 24, 2026 | 184.80 |
| September 23, 2026 | 175.19 |
| September 22, 2026 | 182.58 |
| September 21, 2026 | 186.72 |
| September 18, 2026 | 169.72 |
| September 17, 2026 | 168.91 |
| September 16, 2026 | 173.86 |
| September 15, 2026 | 181.40 |
| September 14, 2026 | 182.58 |
| September 11, 2026 | 174.45 |
| September 10, 2026 | 183.92 |
| September 09, 2026 | 183.92 |
| September 08, 2026 | 183.92 |
| September 04, 2026 | 183.84 |
| Date | Value |
|---|---|
| September 03, 2026 | 171.72 |
| September 02, 2026 | 165.43 |
| September 01, 2026 | 164.55 |
| August 31, 2026 | 179.45 |
| August 28, 2026 | 192.93 |
| August 27, 2026 | 192.93 |
| August 26, 2026 | 188.35 |
| August 25, 2026 | 170.02 |
| August 24, 2026 | 168.54 |
| August 21, 2026 | 170.02 |
| August 20, 2026 | 170.02 |
| August 19, 2026 | 170.02 |
| August 18, 2026 | 172.68 |
| August 17, 2026 | 172.68 |
| August 14, 2026 | 177.41 |
| August 13, 2026 | 197.37 |
| August 12, 2026 | 195.15 |
| August 11, 2026 | 195.15 |
| August 10, 2026 | 180.22 |
| August 07, 2026 | 180.22 |
| August 06, 2026 | 180.22 |
| August 05, 2026 | 180.22 |
| August 04, 2026 | 167.80 |
| August 03, 2026 | 167.80 |
| July 31, 2026 | 172.97 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ascletis Pharma, Inc. | 9.810 |
| CStone Pharmaceuticals Co. Ltd. | 9.788 |
| RemeGen Co., Ltd. | 4.559 |
| InnoCare Pharma Ltd. | 2.888 |
| Adagene, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 26.94 |
| PEG Ratio | -3.885 |
| Price | 14.54 |
| Earnings Yield | -1.04% |
| Market Cap | 13.36B |
| PEGY Ratio | -3.885 |